Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Humana Inc (NYSE: HUM) closed at $264.48 down -7.40% from its previous closing price of $285.61. In other words, the price has decreased by -$7.40 from its previous closing price. On the day, 3.65 million shares were traded. HUM stock price reached its highest trading level at $270.32 during the session, while it also had its lowest trading level at $256.21.
Ratios:
For a deeper understanding of Humana Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 06, 2024, Upgraded its rating to Neutral and sets its target price to $308 from $247 previously.
Bernstein Upgraded its Mkt Perform to Outperform on October 08, 2024, while the target price for the stock was maintained at $308.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 08 ’25 when Diamond Susan M bought 10,959 shares for $249.31 per share.
Huval Timothy S. bought 1,247 shares of HUM for $322,443 on Feb 24 ’25. On Dec 31 ’24, another insider, Huval Timothy S., who serves as the Chief Administrative Officer of the company, sold 3,703 shares for $256.26 each. As a result, the insider received 948,925 and left with 8,181 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 31920885760 and an Enterprise Value of 24189120512. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.56, and their Forward P/E ratio for the next fiscal year is 18.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 1.95. Its current Enterprise Value per Revenue stands at 0.205 whereas that against EBITDA is 7.218.
Stock Price History:
The Beta on a monthly basis for HUM is 0.44, which has changed by -0.18696588 over the last 52 weeks, in comparison to a change of 0.05430484 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $406.46, while it has fallen to a 52-week low of $213.31. The 50-Day Moving Average of the stock is -0.51%, while the 200-Day Moving Average is calculated to be -10.92%.
Shares Statistics:
For the past three months, HUM has traded an average of 1.69M shares per day and 2315050 over the past ten days. A total of 120.64M shares are outstanding, with a floating share count of 120.43M. Insiders hold about 0.22% of the company’s shares, while institutions hold 97.11% stake in the company. Shares short for HUM as of 1743379200 were 3660873 with a Short Ratio of 2.16, compared to 1740700800 on 3660419. Therefore, it implies a Short% of Shares Outstanding of 3660873 and a Short% of Float of 3.4000000000000004.
Dividends & Splits
According to the company, the forward annual dividend rate for HUM is 3.54, from 3.54 in the trailing year. Against a Trailing Annual Dividend Yield of 0.012394524The stock’s 5-year Average Dividend Yield is 0.76. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-03-28 with an ex-dividend date of 1750982400. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
The current assessment of Humana Inc (HUM) involves the perspectives of 22.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $6.28, with high estimates of $8.34 and low estimates of $4.5.
Analysts are recommending an EPS of between $17.0 and $16.22 for the fiscal current year, implying an average EPS of $16.38. EPS for the following year is $14.15, with 23.0 analysts recommending between $16.54 and $10.65.
Revenue Estimates
A total of 15 analysts believe the company’s revenue will be $32.22B this quarter.It ranges from a high estimate of $33.16B to a low estimate of $30.97B. As of the current estimate, Humana Inc’s year-ago sales were $29.61BFor the next quarter, 15 analysts are estimating revenue of $31.61B. There is a high estimate of $32.05B for the next quarter, whereas the lowest estimate is $30.62B.
A total of 19 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $127.35B, while the lowest revenue estimate was $122.38B, resulting in an average revenue estimate of $126.14B. In the same quarter a year ago, actual revenue was $117.76BBased on 19 analysts’ estimates, the company’s revenue will be $129.12B in the next fiscal year. The high estimate is $139.35B and the low estimate is $120.67B.
